JXFGF Stock Price, Chart, Stats & News

Jinxin Fertility Group Limited, established in 2003 and headquartered in Chengdu, China, functions as an investment holding company primarily focused on delivering assisted reproductive services (ARS) across both China and the United States. The company offers a comprehensive range of fertility treatments, encompassing artificial insemination, which can be performed using either a husband's or donor sperm, and advanced in vitro fertilization (IVF) techniques such as conventional IVF with embryo transfer or IVF enhanced by intracytoplasmic sperm injection (ICSI). Supporting these core services, Jinxin also provides patients with nutritional guidance, traditional Chinese medicine therapies, and psychological counseling.